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In this project, we report the engineering of a novel liposome 
(HALNP) embedded PEM substrate (HALNP-PEM) for the 
local and sustained delivery of therapeutic cargo.
• Entrapment is verified and release kinetics are analyzed.
• A cell driven mechanism of release for HALNPs is 
hypothesized.
• Doxorubicin (DOX) is delivered to 21M-T metastatic breast 
cancer in vitro.
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 When designing disease treatments, there are several
disadvantages of introducing free drug to a patient:
• Burst Kinetics, toxic off site effects, and low efficacy due
to systematic dilution
 Drug delivery attempts to solve these problems by
controlling the spatial (location) and temporal (timing)
characteristics of drug release!
 Substrate mediated delivery, the release of drug from a 
surface or object, offers a unique way in which to control 
these characteristics.
• Substrate mediated delivery of cargo has shown great 
promise in applications including drug and gene 
eluding films/scaffolds [1,2], coatings for stents [3] and 
other implantable devices [4]
1. Chen, D. et al. Langmuir: the ACS journal of surfaces and colloids 29, 8328–8334 (2013).
2. Huang, C. L. et al. Drug Discovery Today 19, 714–724, (2014).
3. Kang, S.-H. et al. European heart journal 35, 1147–1158 (2014).
4. Kleiner, L. W. et al. Journal of Controlled Release 181, 1–10 (2014).
5. Ariga, K. et al Expert opinion on drug delivery 8, 633–644 (2011).
6. Ai, H. et al. Cell biochemistry and biophysics 39, 23–43 (2003).
7. Flessner, R. M. et al. Langmuir: the ACS journal of surfaces and colloids 27, 7868–7876 (2011).
8. Saurer, E. M. et al. Biomacromolecules 14, 1696–1704 (2013).
4) IONICALLY EMBEDED PARTICLES ARE STABLE,
RELEASE FROM PEM IS MINIMIZED BY CAPPING POLYMER
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2) POLYELECTROLYTE MULTILAYERS 
(PEMs) AND LIPOSOMES NANOPARTICLES 
(LNPs) PEMs are thin polymer film which are constructed of
layers of oppositely charged polyelectrolytes.
• Simple to assemble on biomedical surfaces
• Have been used to entrap small molecule drugs [5],
proteins [6], and nucleic acids [7,8]
 Liposomes nanoparticles are the most researched,
tested, and commercialized drug delivery carrier.
• Can entrap hydrophilic and hydrophobic cargo
• Easy to functionalize and excellent biocompatibility
 PEM entrapped liposomes have been explored, but
maintaining the stability of the liposomes in the PEM
structure has been the primary advancement to this point.
3) PROJECT OBJECTIVE
Fig. 2. Hyaluronic Acid (HA) decorated lipid nanocarrier fabrication overview and characterization.
Fluorescent Microscopy and release studies demonstrate ionically driven HALNP entrapment, and
minimized HALNP release by addition of capping polymer layers. (A) Lipid nanoparticles (LNPs) were
surface functionalized with HA (HALNPs) via EDC facilitated amide bond formations. (B) Transition Electron
Microscopy (TEM) images of particles pre- and post- HA addition. (C) Preferential deposition of HALNPs on
PLL over SPS topped surfaces. Capillary Force Lithography (CFL) was used to create PLL patterns on
(PLL/SPS)4 and to demonstrate the level of spatial control for nanoparticle adsorption. (D) Fluorescent
Recovery after Photobleaching (FRAP) Analysis pre and post the addition of the capping layer for 10 minutes
(yellow arrows point out particles that have moved). (E) HALNP nanocarrier release profile from the non-
capped [(PLL/SPS)4.5(HALNP)] and capped [(PLL/SPS)4.5(HALNP)(PLL/SPS)2.5] HALNP-PEM platforms.
Fig. 3. 21MT-1 localized uptake of
fluorescently labeled particles. (A)
Flow Cytometry Analysis of percent
cell population FITC positive and per
cell fluorescence directly comparing
nanoparticle uptake between the
HALNP-PEM and HALNP bolus
systems (*P < 0.05, **P < 0.005; n =
3; #denotes significance between a
specific sample type and the
preceding time point following the
same significance scale as the stars).
(B) Phase Contrast and Fluorescent
Microscopy visual investigation of
nanoparticle intracellular delivery on
the HALNP-PEM platform. CFL was
used to pattern HALNPs beneath the
capping layers. Note that only the
cells attached directly above the
particles become fluorescent.
Fig. 1. Project Objective Overview
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7) CONCLUSIONS
 HALNP-PEM system entraps and stabilizes drug loaded
liposomes through ionic interactions.
 The locally driven uptake of fluorescent and drug loaded
nanoparticles supports the hypothesis of a cell mediated
degradation mechanism of the PEM substrate.
 HALNPs are taken up by attached cells, and drug loaded
substrate embedded particles show competitive efficacy.
B
Fig. 4. DOX Toxicity Assay and 21MT-1 localized uptake of DOX 
Therapeutic. (A) Doxorubicin potency assay comparison between Free 
Dox, DOX encapsulated in HALNPs (HALNPDOX) in the bolus form, 
and HALNPDOX nanoparticles embedded into the PEM platform 
(HALNPDOX-PEM). Standard MTT protocol was used to determine the 
percent viable cells at 24 hours. (B) Localized delivery of DOX 
therapeutic. Note that cells attached directly above DOX loaded 
HALNPs become predominantly fluorescent.
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